Minor International PCL (BKK:MINT)

Verve Therapeutics Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17,921	13,319	14,260	22,966	25,097	26,188
Short-Term Investments	-	-	-	44	51	38.22
Cash & Short-Term Investments	17,921	13,319	14,260	23,010	25,148	26,226
Cash Growth	20.81%	-6.60%	-38.03%	-8.50%	-4.11%	96.01%
Accounts Receivable	11,577	10,091	14,242	12,631	9,766	8,167
Other Receivables	2,718	5,369	6,627	6,801	7,197	6,407
Receivables	14,295	15,741	21,114	19,530	17,045	14,675
Inventory	6,299	6,004	5,639	6,006	5,644	5,640
Prepaid Expenses	1,457	1,125	1,062	1,011	887	900.25
Other Current Assets	6,938	5,099	500.5	739.01	689.38	4,622
Total Current Assets	46,909	41,288	42,576	50,296	49,413	52,064
Property, Plant & Equipment	212,693	204,444	213,427	205,552	216,230	211,795
Long-Term Investments	11,417	11,454	10,527	10,507	10,879	11,033
Goodwill	-	13,230	14,061	13,454	13,008	12,579
Other Intangible Assets	70,957	53,295	56,783	54,237	56,570	54,648
Long-Term Accounts Receivable	1,444	640.9	2,077	2,321	2,227	2,238
Long-Term Deferred Tax Assets	9,994	8,336	9,238	9,903	11,110	7,732
Long-Term Deferred Charges	-	87	89	93	128	106.11
Other Long-Term Assets	4,168	4,797	3,336	4,891	3,473	3,951
Total Assets	366,301	346,845	359,196	358,210	369,633	362,327
Accounts Payable	24,610	13,234	14,157	12,793	11,703	8,729
Accrued Expenses	-	11,765	11,138	10,079	6,262	5,851
Short-Term Debt	4,017	106.9	2,100	-	1,502	140.44
Current Portion of Long-Term Debt	7,497	13,556	14,578	21,752	17,396	6,302
Current Portion of Leases	14,085	13,537	14,145	13,086	13,709	12,782
Current Income Taxes Payable	2,114	1,522	1,920	1,350	687.78	430.3
Current Unearned Revenue	498.93	312.72	358	315.34	267.57	353.73
Other Current Liabilities	11,080	7,729	7,999	8,179	6,532	6,649
Total Current Liabilities	63,902	61,762	66,395	67,554	58,058	41,238
Long-Term Debt	87,596	79,488	87,012	98,272	114,483	129,897
Long-Term Leases	77,056	71,970	79,639	75,687	78,988	81,820
Long-Term Unearned Revenue	-	288	196	215	244	315.96
Long-Term Deferred Tax Liabilities	32,187	29,404	30,281	29,244	30,082	25,122
Other Long-Term Liabilities	4,744	3,251	6,955	3,449	6,862	6,202
Total Liabilities	267,116	247,708	271,901	275,601	290,140	286,003
Common Stock	5,670	5,670	5,596	5,275	5,214	5,182
Additional Paid-In Capital	36,105	36,105	33,880	26,307	24,893	24,196
Retained Earnings	5,038	4,740	2,003	2,986	-130.08	15,676
Comprehensive Income & Other	40,423	41,318	35,158	36,491	38,046	21,927
Total Common Equity	87,237	87,834	76,637	71,059	68,023	66,981
Minority Interest	11,949	11,303	10,657	11,550	11,470	9,343
Shareholders' Equity	99,185	99,137	87,295	82,609	79,492	76,324
Total Liabilities & Equity	366,301	346,845	359,196	358,210	369,633	362,327
Total Debt	190,251	178,658	197,475	208,797	226,078	230,941
Net Cash (Debt)	-172,330	-165,339	-183,215	-185,787	-200,930	-204,715
Net Cash Per Share	-30.39	-29.21	-33.44	-34.96	-38.67	-42.14
Filing Date Shares Outstanding	5,670	5,670	5,596	5,275	5,214	5,182
Total Common Shares Outstanding	5,670	5,670	5,596	5,275	5,214	5,182
Working Capital	-16,994	-20,475	-23,820	-17,258	-8,645	10,826
Book Value Per Share	9.91	10.02	8.15	7.99	7.12	6.74
Tangible Book Value	16,280	21,309	5,793	3,368	-1,556	-246.34
Tangible Book Value Per Share	-2.60	-1.72	-4.51	-4.84	-6.22	-6.24
Land	-	60,319	58,664	56,845	58,950	45,153
Buildings	-	115,310	118,439	113,654	115,487	112,472
Machinery	-	39,951	40,627	39,081	38,945	38,708
Construction In Progress	-	3,321	2,269	2,147	3,986	6,313

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.